Anaplastic Large Cell Lymphoma - 340 Studies Found Completed : Study of SGN-30 (Anti-CD30 mAb) in Patients With Primary Cutaneous Anaplastic Large Cell Lymphoma : Large Cell Lymphoma : 2004-12-10 : Drug: SGN-30 Recruiting : Pilot Study of Crizotinib in Relapsed ALK+ Lymphomas : Anaplastic Large Cell Lymphoma, ALK-Positive : 2015-04-03 : Drug: crizotinib Withdrawn : MDX-060 in Patients With Relapsed or Refractory Classic Systemic or Primary Cutaneous Anaplastic Large Cell Lymphoma : Lymphoma, Large-Cell : 2006-03-01 : Drug: MDX-060 Active, not recruiting : Crizotinib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma : Brain and Central Nervous System Tumors Lymphoma Neuroblas : 2009-07-14 : Drug: crizotinib Other: pharmacogenomic st Completed : A Phase 2 Open Label Trial of Brentuximab Vedotin (SGN-35) for Systemic Anaplastic Large Cell Lymphoma : Lymphoma, Large-Cell, Anaplastic Lymphoma, Non-Hodgkin : 2009-03-19 : Drug: brentuximab vedotin 1.8 mg/kg every 3 weeks by IV infusion Recruiting : Study of the Biological Mechanisms Associated With the Immunogenicity in Anaplastic Large Cell Lymphoma ( ALCL ) ALK + : ALCL : 2016-09-07 : Other: Blood sample Recruiting : Brentuximab Vedotin in Chinese Participants With Relapsed/Refractory CD30-Positive Hodgkin Lymphoma (HL) or Systemic Anaplastic Large Cell Lymphoma (sALCL) : Hodgkin Disease Lymphoma, Large-Cell, Anaplastic : 2016-10-18 : Drug: Brentuximab Vedotin Brentuximab vedotin IV infusion. Completed : Monoclonal Antibody Therapy in Treating Patients With Refractory Anaplastic Large Cell Lymphoma or Hodgkin's Lymphoma : Lymphoma : 1999-11-01 : Biological: monoclonal antibody HeFi-1 Recruiting : AT13387 in Treating Patients With Relapsed or Refractory Anaplastic Large Cell Lymphoma, Mantle Cell Lymphoma, or Diffuse Large B-cell Lymphoma : ALK Positive BCL6 Positive Recurrent : 2015-10-08 : Other: Laboratory Biomarker Analysis Withdrawn : Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's Lymphoma : AIDS-related Lymphoma Adult Non-Hodgkin's Lymphoma : 2006-03-29 : Drug: cisplatin Drug: cytarabine <<< Previous | Next >>>